-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明，无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
PURE Bioscience (OTCMKTS:PURE) Stock Price Crosses Above 200 Day Moving Average of $0.20
PURE Bioscience (OTCMKTS:PURE) Stock Price Crosses Above 200 Day Moving Average of $0.20
PURE Bioscience, Inc. (OTCMKTS:PURE – Get Rating)'s stock price crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.20 and traded as high as $0.21. PURE Bioscience shares last traded at $0.21, with a volume of 14,550 shares traded.
PURE Bioscience Trading Up 4.9 %
The firm has a market capitalization of $18.48 million, a price-to-earnings ratio of -5.25 and a beta of 0.01. The stock's 50 day moving average price is $0.21 and its two-hundred day moving average price is $0.20.
About PURE Bioscience
(Get Rating)
PURE Bioscience, Inc develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.
Featured Stories
- Get a free copy of the StockNews.com research report on PURE Bioscience (PURE)
- This Little Known Small Cap Is Up 139%: Is The Stock A Buy?
- A Trio of Q3 Winners With Room to Run
- Can HCA Healthcare Weather the Normalization?
- Can United Natural Foods Fight Both Inflation and the Fed?
- Mullen Automotive Is Ready To Get In Gear
Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
PURE Bioscience, Inc. (OTCMKTS:PURE – Get Rating)'s stock price crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.20 and traded as high as $0.21. PURE Bioscience shares last traded at $0.21, with a volume of 14,550 shares traded.
Pure Bioscience，Inc.(OTCMKTS：Pure-Get Rating)股价周三在交易中突破200日移动均线0.20美元，最高交易价格为0.21美元。Pure Bioscience股票最新报0.21美元，总成交量为14,550股。
PURE Bioscience Trading Up 4.9 %
纯生物科学交易上涨4.9%
The firm has a market capitalization of $18.48 million, a price-to-earnings ratio of -5.25 and a beta of 0.01. The stock's 50 day moving average price is $0.21 and its two-hundred day moving average price is $0.20.
该公司的市值为1848万美元，市盈率为-5.25倍，贝塔系数为0.01。该股的50日移动均线价格为0.21美元，200日移动均线价格为0.20美元。
About PURE Bioscience
关于纯生物科学
(Get Rating)
(获取评级)
PURE Bioscience, Inc develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.
Pure Bioscience公司开发和商业化抗菌产品，为美国和国际上病原体的健康和环境挑战以及卫生控制提供解决方案。该公司制造和分销柠檬酸二氢银(SDC)，这是一种无毒的抗菌剂，可提供残留保护，并与其他化合物一起配制。
Featured Stories
专题报道
- Get a free copy of the StockNews.com research report on PURE Bioscience (PURE)
- This Little Known Small Cap Is Up 139%: Is The Stock A Buy?
- A Trio of Q3 Winners With Room to Run
- Can HCA Healthcare Weather the Normalization?
- Can United Natural Foods Fight Both Inflation and the Fed?
- Mullen Automotive Is Ready To Get In Gear
- 免费获取StockNews.com关于纯生物科学的研究报告(PURE)
- 这个小知名的小盘股上涨了139%：这只股票是买入的吗？
- 第三季度赢家三人组还有运行的空间
- HCA医疗能否经受住正常化的考验？
- 联合天然食品能同时对抗通胀和美联储吗？
- 马伦汽车已做好准备投入使用
Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
获得《纯生物科学日报》的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对Pure Bioscience和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧